Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

3187

Actual shortage: 257 (8%)
Anticipated shortage: 1 (0%)
Avoided shortage: 10 (0%)
Resolved: 2919 (92%)

Discontinuation Reports

435

To be discontinued: 2 (0%)
Discontinued: 410 (94%)
Reversed: 23 (5%)

Late reports

482 (13%)

Overdue reports

11 (4%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-TERBINAFINE 250MG TABLET Resolved 2020-07-23 2020-09-24 120905
TEVA-TERBINAFINE 250MG TABLET Resolved 2023-02-09 2023-07-05 184195
TEVA-TERBINAFINE 250MG TABLET Resolved 2023-06-19 2023-08-17 195629
TEVA-TERBINAFINE 250MG TABLET Resolved 2024-10-11 2025-09-02 240028
TEVA-TERBINAFINE 250MG TABLET Resolved 2024-10-11 2025-09-02 240037
TEVA-TERBINAFINE 250MG TABLET Resolved 2025-01-30 2025-01-30 249182
AERMONY RESPICLICK 55MCG POWDER (METERED DOSE) Resolved 2022-12-01 2023-01-18 176791
AERMONY RESPICLICK 232MCG POWDER (METERED DOSE) Resolved 2022-12-01 2023-04-28 176860
ALERTEC 100MG TABLET Resolved 2022-08-18 2022-09-23 167165
AMPICILLIN SODIUM FOR INJECTION, USP 1000MG POWDER FOR SOLUTION Resolved 2019-06-18 2019-09-19 86939
AMPICILLIN SODIUM FOR INJECTION, USP 2000MG POWDER FOR SOLUTION Resolved 2019-06-18 2019-09-19 86942
AMPICILLIN SODIUM FOR INJECTION, USP 500MG POWDER FOR SOLUTION Resolved 2019-06-27 2019-11-07 87653
AMPICILLIN SODIUM FOR INJECTION, USP 250MG POWDER FOR SOLUTION Resolved 2019-09-05 2019-09-19 93110
AMPICILLIN SODIUM FOR INJECTION, USP 500MG POWDER FOR SOLUTION Resolved 2020-11-06 2021-03-18 128031
AMPICILLIN SODIUM FOR INJECTION, USP 1G POWDER FOR SOLUTION Resolved 2021-05-27 2021-08-06 140036
AMPICILLIN SODIUM FOR INJECTION, USP 1G POWDER FOR SOLUTION Resolved 2021-06-03 2021-08-05 140369
AMPICILLIN SODIUM FOR INJECTION, USP 2G POWDER FOR SOLUTION Resolved 2021-07-08 2021-08-24 142189
AMPICILLIN SODIUM FOR INJECTION, USP 500MG POWDER FOR SOLUTION Resolved 2021-08-13 2021-10-07 144105
AMPICILLIN SODIUM FOR INJECTION, USP 250MG POWDER FOR SOLUTION Resolved 2021-10-28 2021-11-25 148421
AMPICILLIN SODIUM FOR INJECTION, USP 1G POWDER FOR SOLUTION Resolved 2022-01-27 2022-12-20 153739

Showing 301 to 320 of 3187

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-FUROSEMIDE 20MG TABLET Discontinued 2017-06-27 2017-06-27 14039
TEVA-FUROSEMIDE 40MG TABLET Discontinued 2017-06-27 2017-06-27 14042
TEVA-GLYBURIDE 2.5MG TABLET Discontinued 2025-05-28 2025-05-28 258547
TEVA-HALOPERIDOL 20MG TABLET Discontinued 2019-10-25 2019-10-26 97270
TEVA-HYDROCHLOROTHIAZIDE 50MG TABLET Discontinued 2025-05-28 2025-05-28 258383
TEVA-HYDROMORPHONE 1MG TABLET Discontinued 2018-10-19 2018-10-19 64970
TEVA-HYDROMORPHONE 2MG TABLET Discontinued 2018-10-19 2018-10-19 64975
TEVA-HYDROMORPHONE 4MG TABLET Discontinued 2018-10-19 2018-10-19 64983
TEVA-HYDROMORPHONE 8MG TABLET Discontinued 2018-10-19 2018-10-19 64993
TEVA-HYDROMORPHONE 1MG TABLET Discontinued 2020-02-13 2020-02-13 106158
TEVA-HYDROMORPHONE 2MG TABLET Discontinued 2020-02-13 2020-02-13 106161
TEVA-HYDROMORPHONE 4MG TABLET Discontinued 2020-02-13 2020-02-13 106164
TEVA-HYDROMORPHONE 8MG TABLET Discontinued 2020-02-13 2020-02-13 106167
TEVA-IRBESARTAN 75MG TABLET Discontinued 2024-04-01 2024-04-01 224049
TEVA-IRBESARTAN 150MG TABLET Discontinued 2025-06-17 2025-06-17 260527
TEVA-IRBESARTAN 300MG TABLET TABLET Discontinued 2025-06-17 2025-06-17 260546
TEVA-IRBESARTAN HCTZ 300MG 12.5MG TABLET Discontinued 2024-06-28 2024-06-29 231577
TEVA-IRBESARTAN HCTZ 300MG 25MG TABLET Discontinued 2024-06-28 2024-06-29 231580
TEVA-IRBESARTAN HCTZ 150MG 12.5MG TABLET Discontinued 2025-06-17 2025-06-17 260549
TEVA-LAMIVUDINE/ZIDOVUDINE 300MG 150MG TABLET Discontinued 2020-01-24 2020-01-24 104260

Showing 241 to 260 of 435